| Acute Myeloid Leukemia Research | Lifetime | 45 | US 30 | 99.78 |
| Histone Deacetylase Inhibitors Research | Lifetime | 36 | US 25 | 99.49 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 38 | US 20 | 99.58 |
| Acute Lymphoblastic Leukemia research | Lifetime | 88 | US 64 | 99.57 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 87 | US 56 | 99.50 |
| Multiple Myeloma Research and Treatments | Lifetime | 89 | US 49 | 99.38 |
| Protein Degradation and Inhibitors | Lifetime | 92 | US 54 | 99.16 |
| Cancer Genomics and Diagnostics | Lifetime | 445 | US 255 | 99.17 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 320 | US 161 | 99.07 |
| Hematological disorders and diagnostics | Lifetime | 85 | US 46 | 98.52 |
| Neutropenia and Cancer Infections | Lifetime | 125 | US 65 | 98.64 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 295 | US 166 | 98.77 |
| Epigenetics and DNA Methylation | Lifetime | 885 | US 454 | 98.05 |
| Retinoids in leukemia and cellular processes | Lifetime | 379 | US 207 | 96.86 |
| Blood disorders and treatments | Lifetime | 297 | US 119 | 96.52 |
| Acute Myeloid Leukemia Research | 2021-2025 | 1 | US 1 | 99.99 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 1 | US 1 | 99.90 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 1 | US 1 | 99.95 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 4 | US 4 | 99.95 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 5 | US 5 | 99.92 |
| Protein Degradation and Inhibitors | 2021-2025 | 11 | US 4 | 99.67 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 24 | US 13 | 99.58 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 13 | US 6 | 99.44 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 20 | US 7 | 99.72 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 3 | US 3 | 98.92 |
| Cancer Genomics and Diagnostics | 2021-2025 | 79 | US 45 | 99.32 |
| Epigenetics and DNA Methylation | 2021-2025 | 64 | US 24 | 98.33 |
| Neutropenia and Cancer Infections | 2021-2025 | 14 | US 8 | 98.22 |
| Hematological disorders and diagnostics | 2021-2025 | 7 | US 6 | 96.73 |
| Chromatin Remodeling and Cancer | 2021-2025 | 21 | US 8 | 93.84 |
| Cell death mechanisms and regulation | 2021-2025 | 32 | US 6 | 92.11 |
| CAR-T cell therapy research | 2021-2025 | 924 | US 493 | 94.83 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 871 | US 354 | 92.86 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 653 | US 298 | 88.33 |
| HIV/AIDS drug development and treatment | 2021-2025 | 905 | US 304 | 82.36 |
| Phagocytosis and Immune Regulation | 2021-2025 | 504 | US 140 | 74.11 |
